- Home
- ESLA vs CIIT Comparison
ESLA vs CIIT Comparison
Compare ESLA & CIIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- CIIT
- Stock Information
- Founded
- ESLA 2021
- CIIT N/A
- Country
- ESLA United States
- CIIT Hong Kong
- Employees
- ESLA N/A
- CIIT N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- CIIT
- Sector
- ESLA Health Care
- CIIT
- Exchange
- ESLA Nasdaq
- CIIT NYSE
- Market Cap
- ESLA 35.5M
- CIIT 34.6M
- IPO Year
- ESLA N/A
- CIIT N/A
- Fundamental
- Price
- ESLA $0.94
- CIIT $2.01
- Analyst Decision
- ESLA Strong Buy
- CIIT
- Analyst Count
- ESLA 1
- CIIT 0
- Target Price
- ESLA $16.00
- CIIT N/A
- AVG Volume (30 Days)
- ESLA 521.4K
- CIIT 170.3K
- Earning Date
- ESLA 08-20-2025
- CIIT 06-09-2025
- Dividend Yield
- ESLA N/A
- CIIT N/A
- EPS Growth
- ESLA N/A
- CIIT N/A
- EPS
- ESLA N/A
- CIIT N/A
- Revenue
- ESLA N/A
- CIIT $9,464,501.00
- Revenue This Year
- ESLA $101.09
- CIIT N/A
- Revenue Next Year
- ESLA N/A
- CIIT N/A
- P/E Ratio
- ESLA N/A
- CIIT N/A
- Revenue Growth
- ESLA N/A
- CIIT 51.52
- 52 Week Low
- ESLA $0.63
- CIIT $1.60
- 52 Week High
- ESLA $3.23
- CIIT $5.38
- Technical
- Relative Strength Index (RSI)
- ESLA 46.99
- CIIT N/A
- Support Level
- ESLA $0.89
- CIIT N/A
- Resistance Level
- ESLA $1.02
- CIIT N/A
- Average True Range (ATR)
- ESLA 0.09
- CIIT 0.00
- MACD
- ESLA -0.00
- CIIT 0.00
- Stochastic Oscillator
- ESLA 21.16
- CIIT 0.00
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About CIIT TIANCI INTERNATIONAL INC
Tianci International Inc along with its subsidiaries is engaged in sale of components of electronic devices, development of software and websites, technical consulting, and providing maintenance support on customized software. The company's business is predominantly carried out in Hong Kong with a substantial portion of its overall revenue being generated from its Electronic Device Hardware Components Sales segment.